媒體:
97
建立:
2020/12/22
管理者:
TUA秘書處, TUA會務組
  1. 知識庫
  2. ...
  3. 2021半年會
  4. 摘要
  5. 媒體
管理者：TUA秘書處, TUA會務組
  1. 1.
    Podium 01
    1. 1.1
      PD01-1: Treatment and outcomes of prostatic abscess: Comparison of treatment methods
      人氣: 1688, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    2. 1.2
      PD01-2: Comparison of different en bloc HoLEP techniques to reduce the rate of postoperative transient urinary incontinence
      人氣: 1647, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    3. 1.3
      PD01-3: Influencing factors in magnetic resonance imaging of prostate to predict the time of regaining continence after robot-assisted radical prostatectomy
      人氣: 1485, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    4. 1.4
      PD01-4: Photothermal treatment of ESBL E. coli via Fe3O4 nanoparticles
      人氣: 1561, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    5. 1.5
      PD01-5: Identify risk factors of mortality in Fournier's gangrene using Taiwan national health insurance research database
      人氣: 1551, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    6. 1.6
      PD01-6: Sexual transmitted infections (STIs) in group life, especially in military group
      人氣: 1617, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
  2. 2.
    Podium 02
    1. 2.1
      PD02-1: Modified dual time point 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma
      人氣: 1663, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    2. 2.2
      PD02-2: MRE11 expression level predicts poor survival in upper tract urothelial carcinomas
      人氣: 1610, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    3. 2.3
      PD02-3: Determination of PD-L1 expression in circulating tumor cells of clear cell renal cell carcinoma patients and correlation with response to PD-1 inhibitors
      人氣: 1725, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    4. 2.4
      PD02-4: Genome-wide association study (GWAS) of response to androgen deprivation therapy (ADT) in metastatic prostate cancer (PCa)
      人氣: 1613, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    5. 2.5
      PD02-6: Renal arterial pseudoaneurysm after robotic-assisted partial nephrectomy: Single-center analysis of predictive factors
      人氣: 1583, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
  3. 3.
    Podium 03
    1. 3.1
      PD03-1: The effects of different da vinci surgical systems on trifecta and pentafecta rates for robot-assisted laparoscopic partial nephrectomy
      人氣: 1668, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    2. 3.2
      PD03-2: Robotic incisional hernia repair after robotic-assisted radical prostatectomy (RARP): A 3-port approach
      人氣: 1778, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    3. 3.3
      PD03-3: The influence of immediate graft blood flow on early graft function
      人氣: 1590, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    4. 3.4
      PD03-4: Whole ureter reconstruction using yang-monti ileal ureter reconstruction: Successful treatment of challenging conditions
      人氣: 1680, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    5. 3.5
      PD03-5: The apoptosis pathway involved in the spermatogenesis of CFTR-deficient mice
      人氣: 1560, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    6. 3.6
      PD03-6: SOFA (sequential organ failure assessment) score is a valuable tool to evaluate for preoperative percutaneous nephrostomy (PCN) insertion before ureteroscopic lithotripsy (URSL) for prevention postoperative sepsis
      人氣: 1692, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
  4. 4.
    Moderated Poster 01
    1. 4.1
      MP01-1: Immunotherapy with checkpoint inhibitors improves survival in patients with metastatic urothelial carcinoma
      人氣: 1481, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-22
    2. 4.2
      MP01-2: Inherited variants of adiponectin and its receptors are associated with the time to castration-resistant prostate cancer
      人氣: 1610, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    3. 4.3
      MP01-3: Docetaxel rechallenge improves survival in patients with metastatic castration-resistant prostate cancer: A retrospective study
      人氣: 1655, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    4. 4.4
      MP01-4: Management of adverse events in patients with metastatic renal cell carcinoma receiving second-line targeted therapy: Real-world experience in Taiwan
      人氣: 1519, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    5. 4.5
      MP01-5: Combination of prostate health index with mpMRI for better assessment of true tumor boundary in prostate cancer
      人氣: 1517, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    6. 4.6
      MP01-6: Perioperative and long-term oncological outcomes of patients with muscle invasive bladder cancer who underwent radical cystectomy: A single-center experience
      人氣: 1594, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    7. 4.7
      MP01-7: The role of PD-L1 and Ki-67 in upper tract urothelial carcinoma
      人氣: 1481, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    8. 4.8
      MP01-8: Combination of trans-perineal MRI– ultrasound fusion and template-guided mapping biopsy for prostate cancer diagnosis
      人氣: 1538, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    9. 4.9
      MP01-9: Geriatric nutritional risk index as a prognostic marker for patients with metastatic castration resistant prostate cancer receiving docetaxel
      人氣: 1484, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    10. 4.10
      MP01-10: Neoadjuvant immunotherapy as nivolumab and ipilimumab for muscle invasive urothelial bladder cancer: Preliminary report of single hospital
      人氣: 1619, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
  5. 5.
    Moderated Poster 02
    1. 5.1
      MP02-1: Outcome of robotic radical prostatectomy for locally advanced prostate cancer (≥ pT3 or N1)
      人氣: 1748, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    2. 5.2
      MP02-2: Detection of circulating tumor cells in patients with penile squamous cell carcinoma: A preliminary study
      人氣: 1613, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    3. 5.3
      MP02-3: Preoperative monocyte-to-lymphocyte ratio as a non-invasive diagnostic tool for prediction of renal cell carcinoma and oncocytoma in patients with renal tumor
      人氣: 1436, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    4. 5.4
      MP02-4: Metastatic urothelial carcinoma patients treated with immune checkpoint inhibitor based immunotherapy
      人氣: 1493, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    5. 5.5
      MP02-5: Immune checkpoint inhibitors (ICIs) in end-stage renal disease (ESRD) patients with metastatic urothelial carcinoma (mUC)
      人氣: 1502, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    6. 5.6
      MP02-6: Nivolumab (NIVO) in pretreated patients with metastatic renal cell carcinoma (mRCC), a single hospital experience
      人氣: 1649, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    7. 5.7
      MP02-7: Increased cardiovascular risk after androgen deprivation therapies among newly diagnosed prostate cancer patients
      人氣: 1524, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-23
    8. 5.8
      MP02-8: Comparation between penoscrotal approach with perineal approach for artificial sphincter implantation in male urinary incontinence
      人氣: 1546, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    9. 5.9
      MP02-9: The incidence of urethral stricture and bladder neck stricture between bipolar and monopolar transurethral resection of prostate
      人氣: 1594, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    10. 5.10
      MP02-10: Analysis of risk factors of bladder neck contracture following transurethral surgery of prostate
      人氣: 1615, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
  6. 6.
    Moderated Poster 03
    1. 6.1
      MP03-1: The outcome of percutaneous nephrolithotomy (PCNL) with antegrade or retrograde ureteroscopic lithotripsy for complicated renal stone with upper ureter stone
      人氣: 1562, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    2. 6.2
      MP03-2: Hounsfield unit (HU) value and its correlation with indocyanine green (ICG) in patient receiving robotic-assisted adrenalectomy
      人氣: 1658, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    3. 6.3
      MP03-3: An updated reconstruction-related penile fibro-vascular anatomy
      人氣: 1715, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    4. 6.4
      MP03-4: Predictive factors in sperm retrieval by microdissection testicular sperm extraction and pregnancy rate: A single center experience
      人氣: 1466, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    5. 6.5
      MP03-5: Change of pelvic floor tonicity in ketamine-induced cystitis
      人氣: 1661, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    6. 6.6
      MP03-6: The evaluation of correlation between pelvic musculoskeletal dysfunction and interstitial cystitis/ bladder pain syndrome in female patients
      人氣: 1473, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    7. 6.7
      MP03-7: Modified urethral pull through operation for complex pelvic fracture urethral injury: Preliminary report
      人氣: 1695, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    8. 6.8
      MP03-8: Enteroccocus species can be fatal in patients with fournier's gangrene
      人氣: 1550, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    9. 6.9
      MP03-9: The Reconstruction of Chordee-Sharing the experience of CCH in recent 30 Years
      人氣: 1654, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
    10. 6.10
      MP03-10: Clinical factors predicting ureteral stent failure in patients with external ureteral compression
      人氣: 1494, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-24
  7. 7.
    Non-Discussion Poster
    1. 7.1
      NDP01: Outcomes of the pelvic organ-preserving robotic radical cystectomy with neobladder in female patients: Single center experience
      人氣: 1508, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-25
    2. 7.2
      NDP02: New development of diagnosis and prognosis for renal clear cell carcinoma and non-clear cell carcinoma – VGTCH experience
      人氣: 1634, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-25
    3. 7.3
      NDP03: Herpes simplex virus and subsequent risk of prostate cancer: A cohort study in Taiwan
      人氣: 1541, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-25
    4. 7.4
      NDP04: Treatment strategy after PSMA for advanced prostate cancer
      人氣: 1537, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-25
    5. 7.5
      NDP05: Ureteral stent does not reduce incidence of acute kidney injury in patient receiving radical cystectomy and ileal urinary diversion
      人氣: 1579, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-25
    6. 7.6
      NDP06: Primary renal mucinous cystadenoma mimicking hydronephrosis: A case report and literature review
      人氣: 1567, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-25
    7. 7.7
      NDP07: Primary malignant melanoma of the kidney: A rare case report
      人氣: 1458, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-25
    8. 7.8
      NDP08: Holmium laser transurethral resection of huge bladder tumor: A case report
      人氣: 1523, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-25
    9. 7.9
      NDP09: Bilateral testicular adrenal rest tumors in an adult patient with congenital adrenal hyperplasia: A case report and review of literature
      人氣: 1645, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-25
    10. 7.10
      NDP10: MiT family translocation renal cell carcinoma: A case report
      人氣: 2037, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-25
    11. 7.11
      NDP11: Case report: Resection and uretero-pyeloplasty of renal pelvis urothelial carcinoma in solitary kidney
      人氣: 1574, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    12. 7.12
      NDP12: Desmoplastic small round cell tumor of the kidney mimicking renal cell carcinoma: A case report
      人氣: 1430, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    13. 7.13
      NDP13: Metachronous retroperitoneal leiomyosarcoma and liposarcoma: A case report
      人氣: 1537, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    14. 7.14
      NDP14: Dramatic outcome of a patient with prostate adenocarcinoma with brain and dural metastases: A case report and review of the literature
      人氣: 1573, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    15. 7.15
      NDP15: Multilocular cystic renal neoplasm of lower malignant potential (MCRNLMP) presented as a complex cyst: A case report
      人氣: 1635, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    16. 7.16
      NDP16: Mucinous adenocarcinoma of the prostatic urethra: Case report and literature review
      人氣: 1541, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    17. 7.17
      NDP17: Application of transperitoneal laparoscopic partial adrenalectomy in patient with unilateral adenoma
      人氣: 1446, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    18. 7.18
      NDP18: Huge benign prostate (>250gm) a rare case and literature review: Experience of transurethral resection of the prostate enucleatioin with anterior fibromuscular stroma preservation
      人氣: 1548, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    19. 7.19
      NDP19: Retroperitoenal dedifferentiated liposarcoma with rapid recurrence in six months: A case report and literature review
      人氣: 1528, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    20. 7.20
      NDP20: Ureter stone : A case report
      人氣: 1521, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    21. 7.21
      NDP21: A case of empyema after percutaneous nephrostomy insertion and retrograde intrarenal surgery: A case report
      人氣: 1568, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    22. 7.22
      NDP22: Bilateral laparoscopic adrenalectomy in occult ectopic ACTH syndrome: A case report
      人氣: 1524, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    23. 7.23
      NDP23: Application of hand-assisted laparoscopic nephrectomy for huge kidney size in autosomal dominant polycystic kidney disease
      人氣: 1520, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    24. 7.24
      NDP24: Onco-testicular sperm extraction of a metachronous bilateral testicular cancer patient: A case report
      人氣: 1498, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    25. 7.25
      NDP25: Ambulatory strategies for reconstructing penile morphological and erectile function
      人氣: 1566, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    26. 7.26
      NDP26: Advancement of a physiologically therapeutic strategy in managing young patients with erectile dysfunction
      人氣: 1517, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    27. 7.27
      NDP27: Cases report: Promising treatment result of alpha blocker for female primary bladder neck dysfunction presented as refractory frequency
      人氣: 1522, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    28. 7.28
      NDP28: Straddle injury with penile cavernosal artery pseudoaneurysm
      人氣: 1625, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    29. 7.29
      NDP29: Intractable salmonella epididymitis in a patient with systemic lupus erythematosus: A case report and literature review
      人氣: 1551, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    30. 7.30
      NDP30: Emphysematous cystitis in a heart transplantation patient: A case report
      人氣: 1568, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    31. 7.31
      NDP31: Rare differential diagnosis of acute lower abdominal pain: A case report of emphysematous cystitis
      人氣: 1538, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    32. 7.32
      NDP32: Inguinal incarcerated hernia with unilateral cryptorchidism: A case report
      人氣: 1563, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    33. 7.33
      NDP33: An unusual presentation of a 4 cm perineal reproductive median raphe cyst
      人氣: 1748, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    34. 7.34
      NDP34: Urachal remnants abscess presenting with acute abdomen in young female: A case report and literature review
      人氣: 1635, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    35. 7.35
      NDP36: Rare differential diagnosis of acute scrotal pain: Spermatic cord hematoma secondary to varicocele rupture Case report and literature review
      人氣: 1514, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    36. 7.36
      NDP35: Case report: Xanthogranulomatous pyelonephritis
      人氣: 2264, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    37. 7.37
      NDP37: Case report: Pathological phimosis, balanoposthitis with abscess formation
      人氣: 1768, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    38. 7.38
      NDP38: The prostatic utricle cyst associated with cryptorchidism and hypospadias: A case report and literature review
      人氣: 1892, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    39. 7.39
      NDP39: Bilateral cryptorchidism with polydactyly: A case report
      人氣: 1477, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    40. 7.40
      NDP40: Case report: Nearly total bladder prolapse after cutaneous vesicostomy
      人氣: 1879, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    41. 7.41
      NDP41: Case report: Combined cysto-laparoscopic management of infectious urachal cyst with patent urachal duct
      人氣: 1594, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    42. 7.42
      NDP42: Post renal transplantation malignancy: High urothelial carcinoma prevalence single regional hospital experience
      人氣: 1641, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    43. 7.43
      NDP43: Hyperacute antibody-mediated rejection with graft loss in cadaveric kidney transplantation: A case report
      人氣: 1566, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    44. 7.44
      NDP44: Combined tissue and mesh repair of inguinal hernia: Experience review
      人氣: 1541, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    45. 7.45
      NDP45: Self-expansion Allium® ureteral stent for refractory ureteral stricture: The first case report in Taiwan
      人氣: 2317, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    46. 7.46
      NDP46: Ureteroscopic laser incision of huge parapelvic cyst: Two case reports and review of literature
      人氣: 1507, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    47. 7.47
      NDP47: Robot assisted laparoscopic diverticulectomy of urinary bladder: Experience of single hospital
      人氣: 1633, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    48. 7.48
      NDP48: Colovesical fistula with intravesical colonic stent migration
      人氣: 1632, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    49. 7.49
      NDP49: Retroperitoneal bronchogenic cysts: A case report and review of literatures
      人氣: 1602, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
    50. 7.50
      NDP50: Case report: Bilateral hydronephrosis and hematuria due to mesenteric panniculitis
      人氣: 1864, 討論: 0, 發表人: TUA秘書處, 上傳時間: 2020-12-28
地址：台北市 11051 信義區基隆路一段432號6樓之1, 電話：02-2729-0819, 傳真：02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw